Leap Therapeutics held its 2024 Annual Meeting of Stockholders and announced the results of the voting on various matters, including the election of directors, approval of executive compensation, approval of an amendment to the equity incentive plan, and ratification of the appointment of EisnerAmper LLP as the independent registered public accounting firm.